CRSP
CRISPR Therapeutics AGHealthcare$49.51
▲ Bullish
Mkt Cap: $4.75B|Float: 95.6M|SI: 22.7%|DTC: 9.4
Data as of market close Apr 2, 2026
IV Rank
100
IV Pctl
89%
HV 20d
57.5%
52W Range
$30-$78
ATR(14)
$2.07
Exp. Move
±3.3%
P/C Ratio
0.55
Earnings
May 11
GEX Positive
DEX Long
Net Put Premium
IV High
Max Pain Below
Exp. Move Moderate
Low Put/Call
CRSP Key Options Data
- IV Rank
- 100%
- Total GEX
- $0.00B
- Total DEX
- $2.3M
- Max Pain
- $48.00
- Expected Move
- ±3.3%
- Put/Call OI
- 0.55
- Net Premium
- $-0.3M
- Spot Price
- $49.51
Gamma Exposure (GEX)
Delta Exposure (DEX)
Expected Move by Expiration
| Expiration | DTE | Expected Move | Move % | Lower | Upper |
|---|---|---|---|---|---|
| 2026-04-10 | 8 | ±$1.62 | ±3.3% | $47.88 | $51.13 |
| 2026-04-17 | 15 | ±$5.50 | ±11.1% | $44.01 | $55.01 |
| 2026-04-24 | 22 | ±$5.85 | ±11.8% | $43.66 | $55.36 |
| 2026-05-01 | 29 | ±$6.50 | ±13.1% | $43.01 | $56.01 |
| 2026-05-08 | 36 | ±$5.15 | ±10.4% | $44.36 | $54.66 |
| 2026-05-15 | 43 | ±$8.40 | ±17.0% | $41.11 | $57.91 |
Explore CRSP options data including implied volatility rankings, gamma and delta exposure, max pain levels, and expected price moves. AI-generated reports provide directional, income, and earnings analysis.